2005
DOI: 10.1016/j.accreview.2005.08.245
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Electrocardiographic Predictors of a Positive Response to Cardiac Resynchronization Therapy in Advanced Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
67
4
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 53 publications
(78 citation statements)
references
References 21 publications
6
67
4
1
Order By: Relevance
“…The heterogeneity test showed significant differences among the subgroups (80.5% and 73.4%, respectively). However, we did not find significant differences in studies 8,9,11,13 measuring postimplantation QRSd after a certain follow-up period compared with studies 7,10,12,14e18 measuring QRSd immediately after CRT device implantation (À19.37 The American Journal of Cardiology (www.ajconline.org) vs À19.31 ms) without any heterogeneity among the individual studies (I 2 ¼ 0%). In addition, the sensitivity analysis showed that heterogeneity across studies was reduced when we excluded the study by Lecoq et al 9 where the inclusion criteria for QRSd was at least 150 ms (I 2 ¼ 33%) or the study by Zhang et al 18 that enrolled only patients with dilated cardiomyopathy (I 2 ¼ 31%), without changing the overall effect.…”
Section: Resultscontrasting
confidence: 66%
See 1 more Smart Citation
“…The heterogeneity test showed significant differences among the subgroups (80.5% and 73.4%, respectively). However, we did not find significant differences in studies 8,9,11,13 measuring postimplantation QRSd after a certain follow-up period compared with studies 7,10,12,14e18 measuring QRSd immediately after CRT device implantation (À19.37 The American Journal of Cardiology (www.ajconline.org) vs À19.31 ms) without any heterogeneity among the individual studies (I 2 ¼ 0%). In addition, the sensitivity analysis showed that heterogeneity across studies was reduced when we excluded the study by Lecoq et al 9 where the inclusion criteria for QRSd was at least 150 ms (I 2 ¼ 33%) or the study by Zhang et al 18 that enrolled only patients with dilated cardiomyopathy (I 2 ¼ 31%), without changing the overall effect.…”
Section: Resultscontrasting
confidence: 66%
“…In the present analysis, we clearly demonstrated that QRSd shortening predicts both clinical and echocardiographic response. In Alonso 1999 Survival with significantly improved symptoms (at least 1 class down) and exercise tolerance (at least 10% increase on baseline in peak VO 2 ) for at least 6 months Molhoek 2004 Those patients who improved at least 1 class NYHA classification score after 6 months of CRT Lecoq 2005 Patients were classified at 6 months as responders to CRT if they were alive, they had not been re-hospitalized for management of CHF, and the NYHA class had decreased by 1 point, and/or peak VO 2 or 6 min hall-walk increased by > 10% Boriani 2006 A reduction > 15% of LVESV Lellouche 2007 (1) no cardiovascular death, (2) no hospitalization for decompensated HF, and (3) ! 1 point decrease in NYHA functional class.…”
Section: Discussionmentioning
confidence: 99%
“…Lecoq et al investigated the association between ΔQRSd and clinical response to CRT. They revealed that 95 % of responders and 60 % of non-responders exhibited QRS narrowing on biventricular pacing ECG [19]. In our patient cohort, 53.2 % of responders and 18.5 % of non-responders had native QRS narrowing post-CRT.…”
Section: Discussionmentioning
confidence: 67%
“…Alonso et al first reported a shorter QRS duration in responders than in non-responders on biventricular pacing ECG [21]. Lecoq et al revealed that the amount of abbreviation in paced QRS duration positively associated with therapeutic response to CRT [19]. Additionally, Serdoz et al found that more than 40 ms reduction in paced QRS duration could predict hyper-response independently [12].…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation